Andere talen Labcorp Holdings Inc.

Aandelen

LH

US5049221055

Beurs gesloten - Nyse Andere beurzen 22:00:02 24-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
199,6 ^USD	+1,67%		-5,19%	-12,16%

16/05	Laboratory Corp Of America Holdings Insider verkocht aandelen ter waarde van $421.655, volgens een recente SEC filing	MT
16/05	LABORATORY CORPORATION OF AMERICA HOLDINGS : Baird herhaalt koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Some of the biggest splits in Corporate America	23/05
Laboratory of America : Labcorp Announces Retirement of Dr. R. Sanders Williams and Mr. Jean-Luc Bélingard from Its Board of Directors	16/05
Declaration of Voting Results by Laboratory Corporation of America Holdings	16/05
Declaration of Voting Results by Laboratory Corporation of America Holdings	16/05
Declaration of Voting Results by Laboratory Corporation of America Holding	16/05
Laboratory Corp Of America Holdings Insider Sold Shares Worth $421,655, According to a Recent SEC Filing	16/05
Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy	15/05
Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk During Pregnancy	15/05
Labcorp to Webcast Its Annual Meeting of Shareholders	08/05
Invitae Receives Court Approval for Sale to Labcorp	07/05
Healthcare Surprise Billing Of Laboratory Tests	07/05
Tara Health Files an Exempt Solicitation Statement and Recommend Vote for its Proposal	06/05
Fourth Circuit Court Of Appeals Revives Class Action Over Labcorp's Deceptive Patient Acknowledgment Form	02/05
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX	01/05
Tranche Update on Laboratory Corporation of America Holdings (NYSE:LH)'s Equity Buyback Plan announced on December 9, 2021.	30/04
Laboratory of America : Code of Conduct & Ethics	30/04
Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy	29/04
US FDA publishes final rule for laboratory developed tests	29/04
Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B	29/04
Laboratory Corp of America Q1 Adjusted Earnings, Revenue Increase; 2024 Adjusted EPS Outlook Updated	25/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Labcorp Holdings Inc.

Aandelen

LH

US5049221055

Andere talen

Filters